NVST - Envista Holdings Corp Stock Price, Fair Value and News

18.84USD-0.16 (-0.84%)Market Closed

Market Summary

USD18.84-0.16

Market Closed

-0.84%

NVST Alerts

Big fall in earnings (Y/Y)

NVST Stock Price

View Fullscreen

NVST RSI Chart

NVST Valuation

Market Cap

3.2B

Price/Earnings (Trailing)

-26.89

Price/Sales (Trailing)

1.26

EV/EBITDA

181.27

Price/Free Cashflow

12.4

NVST Price/Sales (Trailing)

NVST Profitability

EBT Margin

-2.94%

Return on Equity

-2.91%

Return on Assets

-1.84%

Free Cashflow Yield

8.07%

NVST Fundamentals

NVST Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

-0.57%

Rev. Growth (Qtr)

-3.41%

NVST Earnings

Earnings (TTM)

-120.4M

Earnings Growth (Yr)

-46.12%

Earnings Growth (Qtr)

110.86%

Breaking Down NVST Revenue

Last 7 days

-4.6%

Last 30 days

-7.3%

Last 90 days

-16.0%

Trailing 12 Months

-45.4%

How does NVST drawdown profile look like?

NVST Financial Health

Current Ratio

2.27

Debt/Equity

0.34

Debt/Cashflow

0.23

NVST Investor Care

Shares Dilution (1Y)

4.98%

Diluted EPS (TTM)

-0.71

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.6B	0	0	0
2023	2.6B	2.6B	2.6B	2.6B
2022	2.5B	2.5B	2.6B	2.6B
2021	2.1B	2.4B	2.5B	2.5B
2020	2.5B	2.1B	2.0B	1.9B
2019	2.8B	2.8B	2.8B	2.8B
2018	2.8B	2.8B	2.8B	2.8B
2017	0	0	0	2.8B
2016	0	0	0	2.8B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Envista Holdings Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 15, 2024	hulit barbara b.	acquired	-	-	13,065	-
Mar 15, 2024	hulit barbara b.	acquired	-	-	11,705	-
Feb 25, 2024	conley eric	sold (taxes)	-28,108	22.65	-1,241	svp, orthodontics
Feb 25, 2024	aghdaei amir	sold (taxes)	-755,763	22.65	-33,367	chief executive officer
Feb 25, 2024	keller stephen	acquired	-	-	11,045	principal financial officer
Feb 25, 2024	nance mark e	acquired	-	-	21,530	general counsel
Feb 25, 2024	keller stephen	sold (taxes)	-35,379	22.65	-1,562	principal financial officer
Feb 25, 2024	aghdaei amir	acquired	-	-	48,570	chief executive officer
Feb 25, 2024	reis mischa	sold (taxes)	-93,635	22.65	-4,134	svp, strategy & bus. dev.
Feb 25, 2024	conley eric	acquired	-	-	7,730	svp, orthodontics

Which funds bought or sold NVST recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Arizona State Retirement System	added	2.86	-94,747	1,007,100	0.01%
May 07, 2024	Qsemble Capital Management, LP	reduced	-39.22	-910,603	1,069,540	0.23%
May 07, 2024	Paradice Investment Management LLC	reduced	-21.39	-8,446,130	19,572,900	3.40%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-26.83	-2,436,000	4,527,000	0.01%
May 07, 2024	FIDUCIARY FAMILY OFFICE, LLC	new	-	223,058	223,058	0.09%
May 07, 2024	Reynders McVeigh Capital Management, LLC	sold off	-100	-367,000	-	-%
May 07, 2024	HIGHLAND CAPITAL MANAGEMENT, LLC	sold off	-100	-2,079,990	-	-%
May 07, 2024	Regency Capital Management Inc.\DE	new	-	1,208,010	1,208,010	0.77%
May 07, 2024	Swiss National Bank	added	4.86	-529,438	7,237,130	-%
May 07, 2024	SEI INVESTMENTS CO	reduced	-13.06	-4,834,180	16,422,400	0.02%

Are Funds Buying or Selling NVST?

Are funds buying NVST calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NVST

No. of Funds

NVST Alerts

Big fall in earnings (Y/Y)

Unveiling Envista Holdings Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 15, 2024	lazard asset management llc	0.83%	1,431,194	SC 13G/A
Feb 14, 2024	harris associates l p	6.46%	11,078,748	SC 13G
Feb 09, 2024	massachusetts financial services co /ma/	3.3%	5,690,832	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 08, 2024	morgan stanley	9.3%	15,898,867	SC 13G/A
Jan 24, 2024	blackrock inc.	10.7%	18,278,869	SC 13G/A
Jan 10, 2024	vanguard group inc	10.02%	17,167,767	SC 13G/A
Mar 09, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G
Mar 09, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G
Mar 08, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G

Recent SEC filings of Envista Holdings Corp

View All Filings

Date Filed	Form Type	Document
May 02, 2024	3	Insider Trading
May 01, 2024	10-Q	Quarterly Report
May 01, 2024	8-K	Current Report
May 01, 2024	DEFA14A	DEFA14A
Apr 16, 2024	4	Insider Trading
Apr 15, 2024	8-K	Current Report
Apr 08, 2024	DEFA14A	DEFA14A
Apr 08, 2024	DEF 14A	DEF 14A
Apr 08, 2024	ARS	ARS
Mar 29, 2024	PRE 14A	PRE 14A

Peers (Alternatives to Envista Holdings Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.6B	40.3B	-5.05%	-4.82%	32.45	4.53	-2.84%	-3.08%
BDX	67.4B	19.7B	-3.45%	-6.52%	50.6	3.42	4.82%	-17.56%
ALGN	20.6B	3.9B	-14.54%	-9.65%	44.54	5.26	5.72%	46.72%
BAX	18.2B	14.9B	-15.38%	-17.01%	6.88	1.22	2.98%	207.68%
MID-CAP
ATR	10.0B	3.5B	7.32%	25.05%	31.94	2.82	6.16%	35.06%
HSIC	9.3B	12.5B	0.39%	-2.78%	24.01	0.75	-0.61%	-18.83%
BIO	7.6B	2.6B	-17.82%	-26.90%	-23.72	2.94	-6.25%	-68.62%
XRAY	5.8B	3.9B	-13.74%	-32.04%	-61.76	1.47	0.23%	91.03%
AXNX	3.4B	387.1M	-0.59%	20.47%	-215.56	8.87	30.82%	65.57%
PDCO	2.3B	6.6B	-1.26%	-0.69%	11.98	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.92%	-14.34%	-1.85	0.4	7.94%	-1661.78%
ANIK	423.5M	169.3M	11.74%	12.93%	-5.51	2.5	7.49%	-244.90%
ANGO	236.7M	324.0M	-10.59%	-34.33%	-1.23	0.73	-3.19%	-337.41%
APYX	45.4M	52.3M	-10.27%	-60.90%	-2.43	0.87	17.61%	19.28%
AEMD	3.3M	3.7M	-25.00%	250.00%	-0.27	0.88	5.77%	8.23%

Envista Holdings Corp News

Latest updates

Envista Holdings Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-3.4%	624	646	631	662	627	661	631	646	631	652	607	637	613	616	547	309	456	721	659	712	660
Gross Profit	6.1%	356	336	363	379	363	366	365	370	374	343	356	369	358	340	308	155	251	389	367	394	363
S&GA Expenses	9.5%	285	260	258	273	266	254	264	280	258	272	251	259	238	215	227	242	269	176	252	278	275
R&D Expenses	15.3%	23.00	20.00	22.00	27.00	25.00	25.00	26.00	25.00	24.00	25.00	24.00	26.00	26.00	19.00	20.00	17.00	35.00	14.00	36.00	40.00	43.00
EBITDA Margin	-54.3%	0.01*	0.02*	0.13*	0.14*	0.13*	0.14*	0.12*	0.13*	0.14*	0.14*	0.16*	0.16*	-	-	-	-	-	-	-	-	-
Interest Expenses	-7.2%	13.00	14.00	15.00	17.00	17.00	15.00	12.00	6.00	6.00	11.00	12.00	14.00	18.00	21.00	23.00	15.00	3.00	3.00	0.00	-	-
Income Taxes	387.5%	12.00	2.00	14.00	17.00	12.00	2.00	14.00	15.00	16.00	-5.30	-10.30	-9.00	16.00	-38.90	15.00	-28.80	-11.00	10.00	17.00	16.00	7.00
Earnings Before Taxes	116.4%	35.00	-215	36.00	69.00	56.00	76.00	63.00	59.00	86.00	37.00	70.00	70.00	77.00	71.00	38.00	-122	-28.20	33.00	79.00	77.00	45.00
EBT Margin	-37.4%	-0.03*	-0.02*	0.09*	0.10*	0.10*	0.11*	0.10*	0.10*	0.10*	0.10*	0.12*	0.11*	-	-	-	-	-	-	-	-	-
Net Income	110.9%	24.00	-217	22.00	52.00	44.00	74.00	48.00	47.00	75.00	43.00	93.00	90.00	72.00	91.00	24.00	-59.00	-13.20	56.00	62.00	62.00	38.00
Net Income Margin	-20.3%	-0.05*	-0.04*	0.07*	0.08*	0.08*	0.09*	0.08*	0.10*	0.12*	0.12*	0.14*	0.11*	-	-	-	-	-	-	-	-	-
Free Cashflow	-68.8%	29.00	94.00	77.00	61.00	-14.40	93.00	20.00	10.00	-16.30	127	71.00	101	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.7%	6,556	6,605	6,684	6,607	6,575	6,587	6,412	6,461	6,572	6,574	6,562	6,481	6,322	6,876	6,606	6,665	6,241	6,158	6,118	6,026	5,934
Current Assets	1.6%	1,772	1,744	1,641	1,489	1,414	1,425	1,366	1,388	1,909	1,836	1,766	1,302	1,163	1,591	1,416	1,518	1,114	1,002	979	-	-
Cash Equivalents	0.9%	949	940	824	652	585	607	569	523	1,078	1,074	639	554	441	889	701	822	354	211	193	-	-
Inventory	3.3%	267	259	279	297	307	301	291	286	280	264	274	312	283	216	258	281	312	278	-	-	-
Net PPE	-1.1%	306	310	304	300	298	294	277	264	264	264	266	304	296	275	297	294	290	290	283	-	-
Goodwill	-1.0%	3,260	3,292	3,458	3,494	3,506	3,497	3,400	77.00	3,091	3,132	3,146	3,382	3,373	3,207	3,380	3,334	3,293	3,306	3,283	-	-
Current Liabilities	0.1%	781	781	747	1,151	1,150	1,237	1,258	1,256	1,256	1,208	1,269	1,163	1,136	1,685	679	830	609	709	761	-	-
Short Term Borrowings	0.2%	116	115	115	512	511	510	579	509	508	432	427	422	416	887	4.00	254	4.00	4.00	-	-	-
Long Term Debt	-0.5%	1,391	1,398	1,381	876	874	871	852	864	877	883	888	893	892	908	1,756	1,722	1,547	1,321	1,305	-	-
LT Debt, Non Current	-100.0%	-	1,398	1,381	876	874	871	852	864	877	883	888	893	892	908	1,756	1,722	1,547	1,321	1,305	-	-
Shareholder's Equity	-0.8%	4,140	4,174	4,293	4,311	3,713	4,207	3,958	4,016	563	3,733	0.00	3,869	3,691	3,684	3,558	3,493	3,596	93.00	2.00	-	3.00
Retained Earnings	3.7%	655	631	849	827	775	731	658	610	563	467	381	288	198	126	18.00	-17.60	76.00	93.00	37.00	-	-
Additional Paid-In Capital	0.2%	3,767	3,758	3,750	3,719	3,713	3,699	3,690	3,678	3,668	3,733	3,717	3,708	3,691	3,684	3,674	3,666	3,596	3,590	3,614	-	-
Accumulated Depreciation	1.1%	345	341	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	394	-	-
Shares Outstanding	0.2%	172	172	171	164	164	163	163	163	162	161	161	161	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	2.00	3.00	3.00	3.00	3.00	-	-
Float	-	-	-	-	4,900	-	-	-	4,700	-	-	-	4,400	-	-	-	2,700	-	3,700	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-60.5%	40,300	102,000	95,500	75,100	3,100	110,300	46,700	22,200	3,500	136,000	88,300	120,700	16,600	193,400	148,100	4,700	-62,300	187,000	97,800	121,700	-9,000
Share Based Compensation	144.4%	11,000	4,500	6,000	5,200	15,000	7,400	7,300	8,300	7,500	6,600	7,300	7,900	6,400	5,900	5,000	5,700	6,000	5,900	3,600	4,800	4,100
Cashflow From Investing	15.1%	-10,700	-12,600	-25,000	-2,800	-22,000	-1,100	-69,700	-591,600	5,100	288,600	-3,100	-17,300	-5,500	-5,100	-9,600	-3,000	-51,400	-15,800	-20,700	-26,600	-15,300
Cashflow From Financing	-178.8%	-2,600	3,300	114,500	2,600	-1,500	-68,300	73,700	1,800	5,300	1,800	-4,300	6,500	-469,600	3,800	-244,400	474,600	258,500	-148,100	111,200	-95,100	24,300

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NVST Income Statement

2024-03-29

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 29, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales	$ 623.6	$ 627.2
Cost of sales	267.3	264.5
Gross profit	356.3	362.7
Operating expenses:
Selling, general and administrative	284.9	266.1
Research and development	23.3	24.5
Operating profit	48.1	72.1
Nonoperating (expense) income:
Other income, net	0.1	0.3
Interest expense, net	(12.9)	(16.7)
Income before income taxes	35.3	55.7
Income tax expense	11.7	11.9
Net income	$ 23.6	$ 43.8
Earnings per share:
Earnings - basic (in USD per share)	$ 0.14	$ 0.27
Earnings - diluted (in USD per share)	$ 0.14	$ 0.25
Average common stock and common equivalent shares outstanding:
Basic (in shares)	171.9	163.6
Diluted (in shares)	173.4	177.4

NVST Balance Sheet

2024-03-29

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 29, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 948.5	$ 940.0
Trade accounts receivable, less allowance for credit losses of $19.8 and $17.3, respectively	413.0	407.5
Inventories, net	267.4	258.8
Prepaid expenses and other current assets	143.0	137.4
Total current assets	1,771.9	1,743.7
Property, plant and equipment, net	306.2	309.6
Operating lease right-of-use assets	125.3	125.1
Other long-term assets	174.4	180.5
Goodwill, net	3,259.8	3,292.2
Other intangible assets, net	918.7	954.0
Total assets	6,556.3	6,605.1
Current liabilities:
Short-term debt	115.5	115.3
Trade accounts payable	174.7	179.5
Accrued expenses and other liabilities	458.6	455.7
Operating lease liabilities	32.5	30.3
Total current liabilities	781.3	780.8
Operating lease liabilities	107.5	109.9
Other long-term liabilities	136.7	142.4
Long-term debt	1,390.5	1,398.1
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at March 29, 2024 and December 31, 2023	0.0	0.0
Common stock, $0.01 par value,$500.0 million shares authorized; $173.8 million shares issued and $171.9 million shares outstanding at March 29, 2024; $173.3 million shares issued and $171.5 million shares outstanding at December 31, 2023	1.7	1.7
Additional paid-in capital	3,767.4	3,758.2
Retained earnings	654.8	631.2
Accumulated other comprehensive loss	(283.6)	(217.2)
Total stockholders’ equity	4,140.3	4,173.9
Total liabilities and stockholders’ equity	$ 6,556.3	$ 6,605.1

About Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

CEO	Mr. Amir Aghdaei
WEBSITE	https://envistaco.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	12700

Envista Holdings Corp Frequently Asked Questions

What is the ticker symbol for Envista Holdings Corp? What does NVST stand for in stocks?

NVST is the stock ticker symbol of Envista Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Envista Holdings Corp (NVST)?

As of Wed May 08 2024, market cap of Envista Holdings Corp is 3.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVST stock?

You can check NVST's fair value in chart for subscribers.

What is the fair value of NVST stock?

You can check NVST's fair value in chart for subscribers. The fair value of Envista Holdings Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Envista Holdings Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NVST so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Envista Holdings Corp a good stock to buy?

The fair value guage provides a quick view whether NVST is over valued or under valued. Whether Envista Holdings Corp is cheap or expensive depends on the assumptions which impact Envista Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVST.

What is Envista Holdings Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, NVST's PE ratio (Price to Earnings) is -26.89 and Price to Sales (PS) ratio is 1.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVST PE ratio will change depending on the future growth rate expectations of investors.